Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ALZN - Alzamend Neuro, Inc.
Market Cap 44.50M P/E - EPS this Y 26.70% Ern Qtrly Grth -
Income -7.39M Forward P/E -2.09 EPS next Y -4.80% 50D Avg Chg -20.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -33.00%
Dividend N/A Price/Book 14.81 EPS next 5Y - 52W High Chg -69.00%
Recommedations 2.50 Quick Ratio 0.41 Shares Outstanding 3.89M 52W Low Chg 48.00%
Insider Own 5.24% ROA -214.47% Shares Float 3.76M Beta -0.01
Inst Own 0.98% ROE - Shares Shorted/Prior 69.81K/25.87K Price 0.46
Gross Margin - Profit Margin - Avg. Volume 159,893 Target Price 50.00
Oper. Margin - Earnings Date Sep 11 Volume 76,803 Change 0.50%
Healthcare | Biotechnology | United States
About Alzamend Neuro, Inc.

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Alzamend Neuro, Inc. News
10/16/24 Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
10/16/24 EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's
10/15/24 Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
10/10/24 Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Group’s Virtual Healthcare Conference
08/26/24 Alzamend Neuro Issues Letter to Stockholders
08/19/24 Top Midday Gainers
08/19/24 Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
08/12/24 Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
08/06/24 Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
08/06/24 Alzamend Neuro partners with Mass General for Alzheimer’s treatment trial
08/05/24 EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
07/31/24 Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
07/12/24 Alzamend Neuro Announces Reverse Stock Split
05/22/24 Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
05/14/24 Alzamend Neuro Announces Initial Closing of Private Placement
05/09/24 EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
05/09/24 Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
05/07/24 Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
04/02/24 Insiders Are Buying These 11 Penny Stocks
12/11/23 EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
ALZN Chatroom

User Image Scrood_the_Pooch Posted - 2 days ago

$ALZN Gosh, that wouldn't be the same 'Ascendiant' that is raping you logs with the ATM, would it? Nah, must be a different one...

User Image Jayusaucy Posted - 2 days ago

$ALZN New all time low? 🥱 Where you pumpers at?

User Image Clifden Posted - 2 days ago

$ALZN They’re hypothesizing the outcome 🦃🤓

User Image StockRedBaron Posted - 2 days ago

$ALZN NOT $0 ST---$1.46

User Image Thestocktraderhubzee Posted - 6 days ago

WATCHLIST NOV 11 2024 $AMPX HC Wainwright & Co. Reiterates Buy on Amprius Technologies, Maintains $10 Price Target $AUTL Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target $LTRX Needham Maintains Buy on Lantronix, Lowers Price Target to $5.5 $ALZN Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $35 $TOST Piper Sandler Maintains Neutral on Toast, Raises Price Target to $35

User Image Fuddsblood65 Posted - 1 week ago

$ALZN Expect most if not all medical related stocks to suffer until RFK jr has determined if they are viable! Food too

User Image Mobus123 Posted - 1 week ago

$ALZN

User Image StockHunter75 Posted - 1 week ago

$ALZN 🚨SCAM ALERT🚨

User Image StockHunter75 Posted - 1 week ago

$ALZN This Is A SCAM and you should short it to recoup your losses. It will be under a buck soon and then see a reverse split.

User Image Scrood_the_Pooch Posted - 1 week ago

$ALZN @citroengirl @Andyc545 You have a cosmetics salesman as CEO, a furniture salesman as one of the other 3 employees. Nobody has any medical experience or education whatsoever. Two scrap-heap rent-a-drugs all other bio's/pharma passed on. Company invented by one of the markets greatest shysters so he could give him and his wife shares at $0.0004/ea. What could possibly go wrong?

User Image citroengirl Posted - 1 week ago

$ALZN depressing… as usual. My worst move ever ( can’t even call it investment)

User Image kingitalia Posted - 1 week ago

$ALZN

User Image Scrood_the_Pooch Posted - 1 week ago

PS- slip a few in your pocket for are poor brothers over at $ALZN, boldly weathering this tough market day.

User Image Scrood_the_Pooch Posted - 1 week ago

$ALZN Nice day to run a little ATM, right guys?

User Image Lucky72 Posted - 1 week ago

$ALZN When is going to pay again?

User Image lyn30 Posted - 1 week ago

$ALZN $GRI 🚀🚀💎💎

User Image lyn30 Posted - 2 weeks ago

$ALZN $GRI 🚀🚀🚀🚀

User Image lyn30 Posted - 2 weeks ago

$ALZN Stephan Jackman, CEO of Alzamend

User Image lyn30 Posted - 2 weeks ago

$ALZN $GRI IMO both has potential 🚀🚀🚀

User Image TheNightTrader Posted - 10/30/24

@Mra888 looks like mostly retail. No prints over 8200 shares and only 3 prints over 5000 shs so far today $alzn

User Image Goldenfry Posted - 10/29/24

$ALZN Milton, where are you?

User Image Jayusaucy Posted - 10/29/24

$ALZN 2.5 months later and this pos still hasn’t done anything since $15 pump. Lmaoo. Same longs averaging down holding onto a diluted, declining company since August 🤡can’t make this up

User Image Mobus123 Posted - 10/25/24

$ALZN holding strong

User Image vzlano25 Posted - 10/25/24

$ALZN any time!!

User Image lyn30 Posted - 10/24/24

$LGMK 11.74M Recently fund bought around $10M shares Insiders loaded @ .47 Huge short ( no idea how they took that risk / rationale behind that ) $AKAN - float 4.12M; no cash issues; $TNXP - NDA submitted for fibromyalgia; waiting for FDA date set up news. $ALZN - float 4.27M; Alzheimer's drug in trial; recently biotech run huge suddenly ; IMO potential for that type of violent move.

User Image lyn30 Posted - 10/24/24

$ALZN Low float Alzheimer’s stock who knows it may b next $MNPR

User Image TrumpIsAnIdiot Posted - 10/23/24

$ALZN 1.80 by EOD Let's run

User Image ProInvestAI Posted - 10/22/24

$ALZN Preparing for the move add here

User Image lyn30 Posted - 10/22/24

$ALZN This stock remind me Sava and cvna

User Image Scrood_the_Pooch Posted - 10/21/24

$ALZN Yo-Yo seems to think that 100% dilution thru ATM is good news for logs?

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Katzoff David J Chief Financial Offi.. Chief Financial Officer Sep 26 Buy 0.1931 53,000 10,234 81,000 09/26/23
AULT MILTON C III Director Director May 24 Buy 0.5947 18,000 10,705 383,000 05/26/23
AULT MILTON C III Director Director Feb 15 Buy 0.5973 1,000 597 11,051,001 02/17/23
AULT MILTON C III Director Director Dec 27 Buy 0.58 4,000 2,320 11,050,001 12/29/22
Jackman Stephan Chief Executive Offi.. Chief Executive Officer Sep 19 Buy 1.2252 8,500 10,414 8,500 09/20/22
AULT MILTON C III Director Director Aug 16 Buy 1.0809 15,000 16,214 9,966,667 08/18/22
AULT MILTON C III Director Director Aug 15 Buy 1.0595 14,000 14,833 9,951,667 08/16/22
AULT MILTON C III Director Director Aug 12 Buy 1.04 1,000 1,040 9,937,667 08/15/22
AULT MILTON C III Director Director Jul 27 Buy 0.87 5,700 4,959 9,934,667 07/28/22
AULT MILTON C III Director Director Jul 22 Buy 0.9051 2,300 2,082 9,928,967 07/25/22
AULT MILTON C III Director Director Jul 18 Buy 0.9773 10,000 9,773 9,926,667 07/19/22
AULT MILTON C III Director Director Jun 29 Buy 0.8830 10,000 8,830 9,916,667 06/30/22
AULT MILTON C III Director Director Jun 17 Buy 0.8841 10,000 8,841 9,906,667 06/21/22
AULT MILTON C III Director Director Jun 15 Buy 0.8740 10,000 8,740 9,896,667 06/16/22
AULT MILTON C III Director Director Jun 14 Buy 0.8474 10,000 8,474 9,886,667 06/15/22
AULT MILTON C III Director Director Jun 08 Buy 0.9470 8,000 7,576 9,876,667 06/09/22
AULT MILTON C III Director Director Jun 02 Buy 0.9599 8,000 7,679 9,866,667 06/03/22
AULT MILTON C III Director Director May 26 Buy 0.94 22,000 20,680 9,858,667 05/31/22
AULT MILTON C III Director Director May 24 Buy 0.8886 16,100 14,306 9,836,667 05/26/22
AULT MILTON C III Director Director May 17 Buy 0.98 23,900 23,422 9,815,567 05/18/22
AULT MILTON C III Director Director May 06 Buy 0.93 125,000 116,250 9,791,667 05/13/22
AULT MILTON C III Director Director May 05 Buy 1.0685 100,000 106,850 325,000 05/06/22
AULT MILTON C III Director Director Apr 26 Buy 1.50 2,666,667 4,000,000 9,666,667 04/28/22
Horne William B. Director Director Apr 26 Option 0.0004 250,000 100 500,000 04/28/22
AULT MILTON C III Director Director Apr 22 Buy 0.9378 75,000 70,335 225,000 04/25/22
AULT MILTON C III Director Director Apr 11 Buy 1.1265 50,000 56,325 150,000 04/12/22
McGrath Lynne Fahey Director Director Mar 28 Sell 1.213 25,000 30,325 75,000 04/08/22
AULT MILTON C III Director Director Mar 18 Buy 1.1045 100,000 110,450 100,000 03/21/22
AULT MILTON C III Director Director Feb 01 Option 0.0004 2,250,000 900 2,500,000 02/01/22
AULT MILTON C III Director Director Jan 27 Buy 1.3950 2,500 3,488 6,977,500 01/28/22
AULT MILTON C III Director Director Jan 24 Buy 1.2899 5,000 6,450 6,975,000 01/25/22
Horne William B. Director Director Jan 24 Option 0.004 150,000 600 250,000 01/25/22
AULT MILTON C III Director Director Jan 18 Buy 1.6599 7,000 11,619 6,970,000 01/19/22
AULT MILTON C III Director Director Jan 14 Buy 1.7894 3,000 5,368 6,963,000 01/18/22
AULT MILTON C III Director Director Jan 07 Buy 1.925 3,000 5,775 6,960,000 01/11/22
AULT MILTON C III Director Director Dec 17 Buy 2.3 38,000 87,400 6,920,388 12/20/21
AULT MILTON C III Director Director Nov 30 Buy 2.13 22,319 47,539 6,907,388 12/02/21
AULT MILTON C III Director Director Nov 22 Buy 1.94 19,681 38,181 6,885,069 11/23/21
AULT MILTON C III Director Director Jul 27 Buy 5.02 12,500 62,750 5,341,555 07/27/21
AULT MILTON C III Director Director Jul 22 Buy 5.33 3,500 18,655 5,329,055 07/22/21